Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma

ClinicalTrials.gov ID: NCT00419757

Public ClinicalTrials.gov record NCT00419757. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-week, Randomised, Double Blind, Active-controlled, Multi-centre, Phase IIIB Study Comparing the Efficacy and Safety of SYMBICORT® pMDI 160/4.5 mg x 2 Actuations Twice Daily Versus Budesonide HFA pMDI 160 mg x 2 Actuations Twice Daily, in Adult/Adolescent (> 12 Yrs) Hispanic Subjects With Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the effectiveness and safety of SYMBICORT® pMDI (a medication approved by the Food and Drug Administration(FDA)) in the Hispanic population.

Study identification

NCT ID
NCT00419757
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
558 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2007 (Type not available)
Primary completion
Jun 2008 (Actual)
Completion
Jun 2008 (Actual)
Last update posted
Aug 27, 2012

2007 – 2008

United States locations

U.S. sites
32
U.S. states
8
U.S. cities
32
Facility City State ZIP Site status
Research Site Anaheim California — —
Research Site Chula Vista California — —
Research Site Fresno California — —
Research Site Fullerton California — —
Research Site Los Angeles California — —
Research Site National City California — —
Research Site Rancho Cordova California — —
Research Site Rancho Mirage California — —
Research Site Riverside California — —
Research Site Sacramento California — —
Research Site San Diego California — —
Research Site San Francisco California — —
Research Site Stockton California — —
Research Site Torrance California — —
Research Site Pueblo Colorado — —
Research Site Largo Florida — —
Research Site Miami Florida — —
Research Site Naranja Florida — —
Research Site North Miami Florida — —
Research Site Orlando Florida — —
Research Site Panama City Florida — —
Research Site South Miami Florida — —
Research Site Chicago Illinois — —
Research Site Newburgh New York — —
Research Site Oklahoma City Oklahoma — —
Research Site Philadelphia Pennsylvania — —
Research Site Boerne Texas — —
Research Site El Paso Texas — —
Research Site Fort Worth Texas — —
Research Site Houston Texas — —
Research Site San Antonio Texas — —
Research Site Spring Texas — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00419757, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 27, 2012 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00419757 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →